100 related articles for article (PubMed ID: 2142808)
21. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Nakatsu H; Kume T; Kodama M; Masu C
Hinyokika Kiyo; 1989 Aug; 35(8):1323-7. PubMed ID: 2683648
[TBL] [Abstract][Full Text] [Related]
22. [MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Seguchi T; Nakano E; Miki T; Kondoh M; Nishimura K; Nakamura N; Okuyama A
Gan To Kagaku Ryoho; 1994 Jan; 21(1):59-65. PubMed ID: 8291917
[TBL] [Abstract][Full Text] [Related]
23. [Neoadjuvant chemotherapy for invasive bladder cancer].
Kageyama Y; Kihara K
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
[TBL] [Abstract][Full Text] [Related]
24. [Infiltrating tumors of the bladder. Local response to systemic platinum-based chemotherapy].
Boccon-Gibod L; Adjiman S; Beuzeboc P; Steg A
Ann Urol (Paris); 1989; 23(4):285-8. PubMed ID: 2686541
[TBL] [Abstract][Full Text] [Related]
25. [Study of the combined M-VAC therapy in invasive bladder cancer].
Asano K; Masuda F; Suzuki H; Takamizawa S; Kaneko R
Hinyokika Kiyo; 1991 Dec; 37(12):1645-50. PubMed ID: 1785388
[TBL] [Abstract][Full Text] [Related]
26. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
[TBL] [Abstract][Full Text] [Related]
27. Systemic chemotherapy for muscle invasive bladder cancer.
Ondrus D; Hornák M; Bárdos A; Ondrus B
Neoplasma; 1994; 41(5):263-8. PubMed ID: 7854496
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study of modified M-VAC therapy with one 21-day cycle for advanced urothelial cancer].
Nakanishi S; Matsuzaki M; Morikawa H; Nakano M; Komatsu H
Hinyokika Kiyo; 2004 Oct; 50(10):667-71. PubMed ID: 15575216
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy of metastatic cancer of the bladder. Apropos of 50 patients treated with M-VAC].
Beuzeboc P; Dhote R; Thiounn N; Flam T; Zerbib M; Debré B; Pouillart P
Cancer Radiother; 1998 Apr; 2 Suppl 1():92s-96s. PubMed ID: 9749087
[TBL] [Abstract][Full Text] [Related]
30. [Postoperative adjuvant M-VAC chemotherapy for invasive bladder cancer].
Yamashita S; Taniguchi K; Morimitsu H; Suzu H; Kanetake H; Saito Y; Yushita Y; Sakuragi T
Hinyokika Kiyo; 1992 May; 38(5):519-24. PubMed ID: 1609658
[TBL] [Abstract][Full Text] [Related]
31. [Neoadjuvant intra-arterial chemotherapy followed by partial cystectomy for invasive bladder cancer].
Sekine H; Mine M; Ohya K; Kaneoya F; Yokokawa M
Hinyokika Kiyo; 1992 Feb; 38(2):155-9. PubMed ID: 1561948
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
Nieuwenhuijzen JA; Bex A; Meinhardt W; Kerst JM; Schornagel JH; VAN Tinteren H; Horenblas S
J Urol; 2005 Jul; 174(1):80-5. PubMed ID: 15947583
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
Simon SD; Srougi M
Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
[No Abstract] [Full Text] [Related]
34. Quality of life in patients with advanced bladder cancer treated by tumorectomy and systemic adjuvant polychemotherapy (M-VAC). Our experience in 14 cases.
Valente R; Marini F; Signori GB; Martino F
Arch Esp Urol; 1989; 42(1):87-9. PubMed ID: 2712609
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant treatment of cancer of the bladder with M-VAC/M-VEC, and bladder-sparing policy: preliminary report of a non-randomized study.
Galante E; Ferroni C; Bianchi S; Megale C; Molinaro S; Maymone S
J Exp Ther Oncol; 1996 Jul; 1(4):237-41. PubMed ID: 9414410
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of intra-arterial methotrexate, vinblastine, doxorubicin and cis-platinum for bladder cancer].
Tanabe T; Tanaka G; Okutani T; Nishimoto K; Kawashita E; Yoneda K; Fujii M; Shiraishi T
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2207-11. PubMed ID: 1444487
[TBL] [Abstract][Full Text] [Related]
37. [Two cases of urothelial cancer responsive to high-dose-intensity methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy].
Fukuda H; Mitsumori K; Minagawa S; Kumazawa T; Tadachi K; Iinuma M; Satoh S; Satoh K; Habuchi T; Kato T
Hinyokika Kiyo; 2005 Feb; 51(2):113-6. PubMed ID: 15773365
[TBL] [Abstract][Full Text] [Related]
38. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
[TBL] [Abstract][Full Text] [Related]
39. [Neo-adjuvant M-VAC in the treatment of infiltrating bladder tumors].
García Reboll L; Vera Donoso CD; Ruíz Cerdá JL; Pontones Moreno JL; Martínez Jabaloyas JM; Jiménez Cruz JF
Actas Urol Esp; 1994 Apr; 18(4):271-6. PubMed ID: 7976712
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
